GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,013,000 | +202.3% | 137,905 | +193.9% | 0.00% | – |
| Q3 2020 | $666,000 | -91.9% | 46,916 | -95.5% | 0.00% | -100.0% |
| Q3 2015 | $8,220,000 | -99.9% | 1,044,430 | -2.9% | 0.01% | 0.0% |
| Q2 2015 | $9,748,551,000 | -31.6% | 1,075,999 | -2.0% | 0.01% | -28.6% |
| Q1 2015 | $14,244,460,000 | -1.9% | 1,097,416 | +2.8% | 0.01% | 0.0% |
| Q4 2014 | $14,522,346,000 | +65508.1% | 1,067,035 | -56.8% | 0.01% | -41.7% |
| Q3 2014 | $22,135,000 | -33.2% | 2,467,611 | +0.7% | 0.01% | -29.4% |
| Q2 2014 | $33,140,000 | -99.8% | 2,449,386 | +21.0% | 0.02% | +54.5% |
| Q1 2014 | $20,119,256,000 | -19.1% | 2,024,070 | +8.1% | 0.01% | -21.4% |
| Q4 2013 | $24,877,684,000 | +8.8% | 1,871,910 | -0.6% | 0.01% | 0.0% |
| Q3 2013 | $22,861,926,000 | +83.9% | 1,883,190 | +56.8% | 0.01% | +75.0% |
| Q2 2013 | $12,431,880,000 | – | 1,201,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |